CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Lantheus withdraws, resubmits HSR filing for Curium acquisition

Neutral
AI Analysis

Summary

Lantheus has withdrawn and resubmitted its Hart-Scott-Rodino (HSR) filing for the acquisition of Curium, indicating regulatory procedural activity in the pending transaction.

Importance:5/10
Sentiment:
0.00
M&AHSR FilingRegulatoryLantheusCurium
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 21, 2026 9:35 PM

Read Original